Image de couverture de livre

CAR-T Cell Therapy in Gastrointestinal Surgical Oncology: Expanding Horizons beyond Hematologic Malignancies.

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Melih Can Gül
Format:	Recurso digital
Langue:	anglais
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Hematology/Oncology and Stem Cell Therapy
Publié: (2026)

Integrating Nature Into Oncology: Enhancing Hematological Malignancies Therapies With Natural Medicine
par: Yaoyao Tian, et autres
Publié: (2025)

Strategies to Enhance CAR ‐T Cell Persistence in Hematologic Malignancies: From Molecular Design to Clinical Optimization
par: Mengqi Yu, et autres
Publié: (2025)

Atypical Lymphocytosis Induced by T Cell‐Engaging Therapy in Patients With Hematological Malignancies
par: Tae‐Shin Kim, et autres
Publié: (2025)

Response to Methodological Concerns Regarding Eligibility Criteria and Study Selection in a Systematic Review and Meta‐Analysis of CAR T‐Cell Therapy for Hematologic Malignancies
par: Charalampos Filippatos, et autres
Publié: (2026)

From Bench to Bedside: Emerging Paradigms in CAR‐T Cell Therapy for Solid Malignancies
par: Yang Chen, et autres
Publié: (2025)

Efficacy and Safety of Bendamustine Versus Fludarabine and Cyclophosphamide as Lymphodepleting Regimens for CAR ‐T Therapy in Hematological Malignancies: A Systematic Review and Meta‐Analysis
par: Akihiro Miyashita, et autres
Publié: (2026)

Oncolog-Hematolog.ro
Publié: (2021)

Journal of Hematology & Oncology
Publié: (2008)

Experimental Hematology & Oncology
Publié: (2012)

International Journal of Hematology-Oncology and Stem Cell Research
Publié: (2020)

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity
par: Omar Alqaisi, et autres
Publié: (2026)

Cytomegalovirus Infection After Chimeric Antigen Receptor T‐Cell Therapy or Bispecific Antibody Treatment for Hematologic Malignancies
par: Juhui Han, et autres
Publié: (2025)

Hematology, Transfusion and Cell Therapy
Publié: (2018)

healthbook TIMES. Oncology Hematology
Publié: (2022)

Clinical Pediatric Hematology-Oncology
Publié: (2020)

Pediatric Hematology Oncology Journal
Publié: (2017)

ESMO Gastrointestinal Oncology
Publié: (2024)

The Neurocognitive Impact of CAR T Cell Therapy in Hematological Cancers: A Systematic Review of Cognitive Function, Quality of Life, and Psychological Outcomes
par: Ashvath Arumugam Pillai, et autres
Publié: (2025)

Expert Perspective: Hematologic Malignancies and Vasculitis
par: Michelle L. Robinette, et autres
Publié: (2025)

Late Immune Effector Cell‐Associated Hematologic Toxicity After CD19 CAR ‐T Therapy: Incidence, Clinical Course, and Resource Utilization
par: Philippe Giguère, et autres
Publié: (2026)

CAR‐T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View
par: Sara Capolla, et autres
Publié: (2025)

Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancy
par: Patrick C. K. Tam, et autres
Publié: (2026)

Research Advances in the Application of Aptamers for Hematologic Malignancies
par: Mingyan Wu, et autres
Publié: (2026)

Targeting Oncogenic Drivers and Signaling Pathways in Hematologic Malignancies
Publié: (2023)

Surgical Ophthalmic Oncology
Publié: (2020)

Outcomes of Wild Type and TP53 ‐Mutated B Cell Malignancy Patients Receiving CAR ‐T Cell Therapy: A Systematic Review and Meta‐Analysis
par: Wenxin Qi, et autres
Publié: (2025)

Postoperative Care and Management in Pediatric Hematology‐Oncology Patients
par: Shachi Srivatsa, et autres
Publié: (2026)

Using test particle sum rules to construct accurate functionals in classical Density Functional Theory
par: Gül, Melih, et autres
Publié: (2024)

Using test particle sum rules to improve approximations in classical DFT : White-Bear and White-Bear mark II versions of the Lutsko Functional
par: Gül, Melih, et autres
Publié: (2026)

Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies
par: Amanda E. Marinoff, et autres
Publié: (2025)

Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies
par: Alejandro Chara, et autres
Publié: (2025)

Concentration–QTc Analysis of Valemetostat in Patients With Hematologic Malignancies
par: Masaya Tachibana, et autres
Publié: (2025)

Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings
par: Amrit S. Gonugunta, et autres
Publié: (2026)

Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults With SCD
par: Mohamed A. E. Ali, et autres
Publié: (2025)

Clinical Surgical Oncology
Publié: (2024)

Nanotechnology‐Assisted CAR‐T‐Cell Therapy for Tumor Treatment
par: Yixin Wang, et autres
Publié: (2024)

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies
par: Yan Sun, et autres
Publié: (2025)

Comprehensive Framework for Oncology Pharmacist‐Led Parenteral Anticancer Therapy Patient Education: The Opinion of the American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network
par: Erin Hickey Zacholski, et autres
Publié: (2025)

Unusual Co‐Occurrence of Multiple Myeloma and AML in a Patient With Germline CEBPA Variant. Expanding the Spectrum of Hereditary Hematologic Malignancies
par: María Noel Spangenberg, et autres
Publié: (2025)